Population Assessment of Tobacco and Health (PATH) Study [United States] Master Linkage Files

The PATH Study was launched in 2011 to inform the Food and Drug Administration's regulatory activities under the Family Smoking Prevention and Tobacco Control Act (TCA). The PATH Study is a collaboration between the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), and the Center for Tobacco Products (CTP), Food and Drug Administration (FDA). The study sampled over 150,000 mailing addresses across the United States to create a national sample of tobacco users and non-users. 45,971 adults and youth constitute the first (baseline) wave, Wave 1, of data collected by this longitudinal cohort study. These 45,971 adults and youth along with 7,207 "shadow youth" (youth ages 9 to 11 sampled at Wave 1) make up the 53,178 participants that constitute the Wave 1 Cohort. Respondents are asked to complete an interview at each follow-up wave. Youth who turn 18 by the current wave of data collection are considered "aged-up adults" and are invited to complete the Adult Interview. Additionally, "shadow youth" are considered "aged-up youth" upon turning 12 years old, when they are asked to complete an interview after parental consent. At Wave 4, a probability sample of 14,098 adults, youth, and shadow youth ages 10 to 11 was selected from the civilian, noninstitutionalized population at the time of Wave 4. This sample was recruited from residential addresses not selected for Wave 1 in the same sampled PSUs and segments using similar within-household sampling procedures. This "replenishment sample" was combined for estimation and analysis purposes with Wave 4 adult and youth respondents from the Wave 1 Cohort who were in the civilian, noninstitutionalized population at the time of Wave 4. This combined set of Wave 4 participants, 52,731 participants in total, forms the Wave 4 Cohort. Please refer to the Restricted-Use Files User Guide that provides further details about children designated as "shadow youth" and the formation of the Wave 1 and Wave 4 Cohorts. Dataset 0001 (DS0001) contains the data from the Public-Use Master Linkage File (PUF-MLF). This file contains 30 variables and 67,276 cases. The file provides a master list of every person's unique identification number and what type of respondent they were in each wave for data that are available in the Public-Use Files and Special Collection Public-Use Files. Dataset 0002 (DS0002) contains the data from the Restricted-Use Master Linkage File (RUF-MLF). This file contains 93 variables and 67,276 cases. The file provides a master list of every person's unique identification number and what type of respondent they were in each wave for data that are available in the restricted-Use Files, Special Collection Restricted-Use Files, and Biomarker Restricted-Use Files.

PATH 研究，始于2011年，旨在为美国食品药品监督管理局（FDA）根据《家庭吸烟预防与烟草控制法案》（TCA）所进行的监管活动提供信息。PATH 研究 由美国药物滥用研究所（NIDA）、美国国立卫生研究院（NIH）以及食品药品监督管理局下的烟草产品中心（CTP）共同发起。研究通过对美国超过15万个邮寄地址的抽样，构建了一个全国性的烟草使用者与非使用者样本。其中，45,971名成人和青少年构成了该纵向队列研究的第一波（基线）数据，即 Wave 1。这45,971名成人和青少年，以及7,207名“影子青少年”（在 Wave 1 中抽取的9至11岁青少年）共同构成了53,178名 Wave 1 队列参与者。受访者在每个后续波次中均需完成一次访谈。在当前数据收集波次中达到18岁的青少年被视为“成年化青少年”，并被邀请完成成人访谈。此外，“影子青少年”在满12岁时被视为“成年化青少年”，此时在家长同意后，他们需完成一次访谈。在 Wave 4 中，从 Wave 4 时的民用、非机构化人口中，随机抽取了14,098名成人、青少年和10至11岁的“影子青少年”作为样本。该样本来自未被 Wave 1 选择为样本的同一抽样PSU和区段内的居住地址，并采用类似的户内抽样程序进行招募。这一“补充样本”在估计和分析目的上与 Wave 1 队列中的 Wave 4 成人和青少年受访者相结合，形成包含52,731名参与者的 Wave 4 队列。请参考《受限使用文件用户指南》，以获取关于被指定为“影子青少年”的儿童以及 Wave 1 和 Wave 4 队列形成的进一步详细信息。数据集 0001（DS0001）包含来自公共使用主链接文件（PUF-MLF）的数据。该文件包含30个变量和67,276个案例，提供了每个个体的唯一识别号码以及他们在每个波次中的受访者类型，这些数据均可在公共使用文件和特别收集的公共使用文件中找到。数据集 0002（DS0002）包含来自受限使用主链接文件（RUF-MLF）的数据。该文件包含93个变量和67,276个案例，提供了每个个体的唯一识别号码以及他们在每个波次中的受访者类型，这些数据可在受限使用文件、特别收集的受限使用文件和生物标志物受限使用文件中找到。